Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth M. Van Cott, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Tripathi MM, Tshikudi DM, Hajjarian Z, Hack DC, Van Cott EM, Nadkarni SK. Comprehensive Blood Coagulation Profiling in Patients Using iCoagLab: Comparison Against Thromboelastography. Thromb Haemost. 2020 Jul; 120(7):1116-1127. PMID: 32572866.
    Citations:    
  2. Hayward CPM, George TI, Van Cott EM, Smock KJ. Patient advocacy and its importance to laboratory medicine practice. Int J Lab Hematol. 2020 06; 42 Suppl 1:21-22. PMID: 32543067.
    Citations:    
  3. Grabowski EF, Van Cott EM, Bornikova L, Boyle DC, Silva RL. Differentiation of Patients with Symptomatic Low von Willebrand Factor from Those with Asymptomatic Low von Willebrand Factor. Thromb Haemost. 2020 May; 120(5):793-804. PMID: 32369850.
    Citations:    
  4. Maryamchik E, Van Cott EM. Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V Leiden) Testing Using aPTT-Based Methods. Arch Pathol Lab Med. 2020 Feb 26. PMID: 32101451.
    Citations:    
  5. Van Cott EM, Orlando C, Moore GW, Cooper PC, Meijer P, Marlar R. Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH. J Thromb Haemost. 2020 01; 18(1):17-22. PMID: 31894660.
    Citations:    
  6. Frydman GH, Boyer EW, Nazarian RM, Van Cott EM, Piazza G. Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620943671. PMID: 32702995.
    Citations:    
  7. Liederman Z, Van Cott EM, Smock K, Meijer P, Selby R. Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testing. J Thromb Haemost. 2019 12; 17(12):2123-2130. PMID: 31420903.
    Citations:    
  8. Frydman GH, Ellett F, Van Cott EM, Hayden D, Majmudar M, Vanderburg CR, Dalzell H, Padmanabhan DL, Davis N, Jorgensen J, Toner M, Fox JG, Tompkins RG. A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting. Crit Care Explor. 2019 Aug; 1(8):e0024. PMID: 32166266.
    Citations:    
  9. Moore GW, Van Cott EM, Cutler JA, Mitchell MJ, Adcock DM. Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH. J Thromb Haemost. 2019 09; 17(9):1555-1561. PMID: 31317658.
    Citations:    
  10. Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM, Wirth D, Kaatz S. Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum. Am J Hematol. 2019 06; 94(6):697-709. PMID: 30916798.
    Citations:    
  11. Van Cott EM, Smock KJ, Lippi G. Innovations in Thrombosis and Hemostasis: A Glimpse Towards the Future of Diagnostic Analyzers. Semin Thromb Hemost. 2019 Apr; 45(3):225-227. PMID: 30943570.
    Citations:    
  12. Villalba JA, Van Cott EM. High frequency of false-positive results of aPTT-based lupus anticoagulant tests in patients receiving argatroban. Am J Hematol. 2019 06; 94(6):E166-E169. PMID: 30883898.
    Citations:    
  13. Guddati AK, Rosovsky RP, Van Cott EM, Kuter DJ. Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease. Int J Lab Hematol. 2019 Jun; 41(3):325-330. PMID: 30735311.
    Citations:    
  14. Favaloro EJ, Jennings I, Olson J, Van Cott EM, Bonar R, Gosselin R, Meijer P. Towards harmonization of external quality assessment/proficiency testing in hemostasis. Clin Chem Lab Med. 2018 12 19; 57(1):115-126. PMID: 29668440.
    Citations:    Fields:    
  15. Al-Samkari H, Van Cott EM, Kuter DJ. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Ann Hematol. 2019 Mar; 98(3):581-588. PMID: 30446804.
    Citations:    Fields:    
  16. Chen D, Uhl CB, Bryant SC, Krumwiede M, Barness RL, Olson MC, Gossman SC, Erdogan Damgard S, Gamb SI, Cummins LA, Charlesworth JE, Wood-Wentz CM, Salisbury JL, Plumhoff EA, Van Cott EM, He R, Warad DM, Pruthi RK, Heit JA, Nichols WL, White JG. Diagnostic laboratory standardization and validation of platelet transmission electron microscopy. Platelets. 2018 Sep; 29(6):574-582. PMID: 29863946.
    Citations:    Fields:    Translation:HumansCells
  17. Kim YA, Lewandrowski KB, Lucien FA, Van Cott EM. The effects of transport temperature and time on routine and specialized coagulation assays. Blood Coagul Fibrinolysis. 2018 Mar; 29(2):184-188. PMID: 29356700.
    Citations:    Fields:    Translation:Humans
  18. Maryamchik E, Rosenbaum MW, Van Cott EM. Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden). Arch Pathol Lab Med. 2018 Jan; 142(1):70-74. PMID: 28920711.
    Citations:    Fields:    Translation:Humans
  19. Tripathi MM, Egawa S, Wirth AG, Tshikudi DM, Van Cott EM, Nadkarni SK. Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor. Sci Rep. 2017 08 23; 7(1):9169. PMID: 28835607.
    Citations:    Fields:    
  20. Tshikudi DM, Tripathi MM, Hajjarian Z, Van Cott EM, Nadkarni SK. Optical sensing of anticoagulation status: Towards point-of-care coagulation testing. PLoS One. 2017; 12(8):e0182491. PMID: 28771571.
    Citations:    Fields:    Translation:HumansAnimals
  21. Van Cott EM, Roberts AJ, Dager WE. Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy". Semin Thromb Hemost. 2017 09; 43(6):644. PMID: 28609797.
    Citations:    Fields:    Translation:Humans
  22. Shea BS, Probst CK, Brazee PL, Rotile NJ, Blasi F, Weinreb PH, Black KE, Sosnovik DE, Van Cott EM, Violette SM, Caravan P, Tager AM. Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis. JCI Insight. 2017 May 04; 2(9). PMID: 28469072.
    Citations: 2     Fields:    
  23. Van Cott EM, Roberts AJ, Dager WE. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors. Semin Thromb Hemost. 2017 Apr; 43(3):270-276. PMID: 28052306.
    Citations: 1     Fields:    Translation:Humans
  24. Van Cott EM, Smock KJ, Chen D, Hsu P, Zantek ND, Meijer P. Testing for dabigatran and rivaroxaban by clinical laboratories. Am J Hematol. 2016 Nov; 91(11):E464-E467. PMID: 27458812.
    Citations:    Fields:    Translation:Humans
  25. Zantek ND, Hayward CP, Simcox TG, Smock KJ, Hsu P, Van Cott EM. An Assessment of the State of Current Practice in Coagulation Laboratories. Am J Clin Pathol. 2016 Sep; 146(3):378-83. PMID: 27510716.
    Citations: 1     Fields:    Translation:Humans
  26. Smock KJ, Plumhoff EA, Meijer P, Hsu P, Zantek ND, Heikal NM, Van Cott EM. Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories. Thromb Haemost. 2016 07 04; 116(1):50-7. PMID: 27075008.
    Citations:    Fields:    Translation:Humans
  27. Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016 Jan; 91(1):46-9. PMID: 26492443.
    Citations: 5     Fields:    Translation:Humans
  28. Fitzsimons MG, Vlahakes G, Makar R, Dilley J, Wright C, Van Cott EM, Murali M. Deep Hypothermic Circulatory Arrest in a Patient With Cold-Induced Urticaria. Ann Thorac Surg. 2015 Aug; 100(2):722-3. PMID: 26234851.
    Citations:    Fields:    Translation:Humans
  29. Zantek ND, Hsu P, Meijer P, Smock KJ, Plumhoff EA, Refaai MA, Van Cott EM. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. Int J Lab Hematol. 2015 May; 37 Suppl 1:99-107. PMID: 25976967.
    Citations:    Fields:    Translation:Humans
  30. Kim YA, Gosselin R, Van Cott EM. The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays. Int J Lab Hematol. 2015 Aug; 37(4):e81-4. PMID: 25515302.
    Citations: 1     Fields:    Translation:HumansCells
  31. Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014 Dec; 89(12):1147-50. PMID: 25293789.
    Citations: 4     Fields:    Translation:Humans
  32. Takahashi K, Ohtani K, Larvie M, Moyo P, Chigweshe L, Van Cott EM, Wakamiya N. Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC). J Thromb Thrombolysis. 2014 Oct; 38(3):331-8. PMID: 24474086.
    Citations: 6     Fields:    Translation:Humans
  33. Yeh H, Machaidze Z, Wamala I, Fraser JW, Navarro-Alvarez N, Kim K, Schuetz C, Shi S, Zhu A, Hertl M, Elias N, Farkash EA, Vagefi PA, Varma M, Smith RN, Robson SC, Van Cott EM, Sachs DH, Markmann JF. Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Xenotransplantation. 2014 Sep-Oct; 21(5):454-64. PMID: 25130043.
    Citations: 4     Fields:    Translation:Animals
  34. Branda JA, Dighe AS, Dzik W, Ferraro MJ, Flood J, Lee-Lewandrowski E, Makar R, Mandokolathur M, Rosenberg ES, Saidman S, Sluss P, Sohani AR, Stowell C, Van Cott EM, Lewandrowski KB. The practice of clinical pathology: a quantitative description of laboratory director activities at a large academic medical center. Am J Clin Pathol. 2014 Aug; 142(2):144-9. PMID: 25015853.
    Citations: 1     Fields:    Translation:Humans
  35. Crotty R, Nazarian RM, Song PI, Van Cott EM. Heparin, warfarin, or calciphylaxis? Am J Hematol. 2014 Jul; 89(7):785-6. PMID: 24470428.
    Citations:    Fields:    Translation:Humans
  36. Tripathi MM, Hajjarian Z, Van Cott EM, Nadkarni SK. Assessing blood coagulation status with laser speckle rheology. Biomed Opt Express. 2014 Mar 01; 5(3):817-31. PMID: 24688816.
    Citations: 14     
  37. Schaefer JH, Leung W, Wu L, Van Cott EM, Lok J, Whalen M, van Leyen K, Lauer A, van Ryn J, Lo EH, Foerch C. Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation. J Cereb Blood Flow Metab. 2014 May; 34(5):870-5. PMID: 24549187.
    Citations: 6     Fields:    Translation:Animals
  38. Hsu P, Zantek ND, Meijer P, Hayward CP, Brody J, Zhang X, Smock KJ, Van Cott EM. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results. Semin Thromb Hemost. 2014 Mar; 40(2):232-8. PMID: 24497117.
    Citations:    Fields:    Translation:Humans
  39. Smock KJ, Ledford-Kraemer MR, Meijer P, Hsu P, Van Cott EM. Proficiency testing results for heparin-induced thrombocytopenia in north america. Semin Thromb Hemost. 2014 Mar; 40(2):254-60. PMID: 24497121.
    Citations: 1     Fields:    Translation:Humans
  40. Van Cott EM. Laboratory test interpretations and algorithms in utilization management. Clin Chim Acta. 2014 Jan 01; 427:188-92. PMID: 24080245.
    Citations: 3     Fields:    Translation:Humans
  41. Arpino PA, Goeller AJ, Fatalo A, Van Cott EM. Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2015 Apr; 21(3):260-5. PMID: 23965335.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  42. Zantek ND, Hsu P, Refaai MA, Ledford-Kraemer M, Meijer P, Van Cott EM. Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results. Int J Lab Hematol. 2013 Jun; 35(3):314-21. PMID: 23590660.
    Citations:    Fields:    Translation:HumansAnimals
  43. Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD. External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med. 2012 Jul; 136(7):789-95. PMID: 22742551.
    Citations: 1     Fields:    Translation:Humans
  44. Van Cott EM. Re: 24-year-old man with previously diagnosed hemophilia. Clin Chem. 2012 Jul; 58(7):1089. PMID: 22745258.
    Citations:    Fields:    Translation:Humans
  45. Hayward CP, Moffat KA, Plumhoff E, Timleck M, Hoffman S, Spitzer E, Van Cott EM, Meijer P. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost. 2012 Sep; 38(6):622-31. PMID: 22718255.
    Citations:    Fields:    Translation:HumansCells
  46. Baron JM, Johnson SM, Ledford-Kraemer MR, Hayward CP, Meijer P, Van Cott EM. Protein C assay performance: an analysis of North American specialized coagulation laboratory association proficiency testing results. Am J Clin Pathol. 2012 Jun; 137(6):909-15. PMID: 22586050.
    Citations: 2     Fields:    Translation:Humans
  47. Fritsma GA, Dembitzer FR, Randhawa A, Marques MB, Van Cott EM, Adcock-Funk D, Peerschke EI. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization. Am J Clin Pathol. 2012 Jun; 137(6):904-8. PMID: 22586049.
    Citations: 4     Fields:    Translation:Humans
  48. Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012 May; 87 Suppl 1:S141-5. PMID: 22473649.
    Citations: 76     Fields:    Translation:Humans
  49. Garcia D, Van Cott EM, Kouides PA. Introductory remarks for the THSNA meeting proceedings: hemostasis and thrombosis at the cutting edge. Am J Hematol. 2012 May; 87 Suppl 1:S1. PMID: 22473910.
    Citations:    Fields:    Translation:Humans
  50. Johnson NV, Khor B, Van Cott EM. Advances in laboratory testing for thrombophilia. Am J Hematol. 2012 May; 87 Suppl 1:S108-12. PMID: 22473489.
    Citations: 5     Fields:    Translation:Humans
  51. Hayward CP, Moffat KA, Plumhoff E, Van Cott EM. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices. Am J Hematol. 2012 May; 87 Suppl 1:S45-50. PMID: 22367923.
    Citations:    Fields:    Translation:Humans
  52. Peña JA, Lewandrowski KB, Lewandrowski EL, Gregory K, Baron JM, Van Cott EM. Evaluation of the i-STAT point-of-care capillary whole blood prothrombin time and international normalized ratio: comparison to the Tcoag MDAII coagulation analyzer in the central laboratory. Clin Chim Acta. 2012 Jun 14; 413(11-12):955-9. PMID: 22330876.
    Citations: 2     Fields:    Translation:Humans
  53. Grabowski EF, Curran MA, Van Cott EM. Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow device. Thromb Res. 2012 Apr; 129(4):e18-24. PMID: 22265674.
    Citations: 1     Fields:    Translation:Humans
  54. Kitchens WH, Yeh H, Van Cott EM, Elias N, Kawai T, Markmann JF, Hertl M. Protein S deficiency in a living liver donor. Transpl Int. 2012 Feb; 25(2):e23-6. PMID: 22175543.
    Citations:    Fields:    Translation:Humans
  55. Schlunk F, Van Cott EM, Hayakawa K, Pfeilschifter W, Lo EH, Foerch C. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke. 2012 Jan; 43(1):246-9. PMID: 21998055.
    Citations: 9     Fields:    Translation:Animals
  56. Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, Steinmetz H, Schaffer CB, Lo EH, Foerch C. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation. 2011 Oct 11; 124(15):1654-62. PMID: 21911784.
    Citations: 27     Fields:    Translation:Animals
  57. Saenz AJ, Johnson NV, Van Cott EM. Acquired activated protein C resistance caused by lupus anticoagulants. Am J Clin Pathol. 2011 Sep; 136(3):344-9. PMID: 21846908.
    Citations: 2     Fields:    Translation:Humans
  58. Lewandrowski EL, Van Cott EM, Gregory K, Jang IK, Lewandrowski KB. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus. Am J Clin Pathol. 2011 May; 135(5):741-8. PMID: 21502428.
    Citations: 1     Fields:    Translation:Humans
  59. Lauer A, Schlunk F, Van Cott EM, Steinmetz H, Lo EH, Foerch C. Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2011 Aug; 31(8):1736-42. PMID: 21386857.
    Citations: 11     Fields:    Translation:AnimalsCells
  60. Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD. External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia. Arch Pathol Lab Med. 2011 Feb; 135(2):227-32. PMID: 21284443.
    Citations: 1     Fields:    Translation:Humans
  61. Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol. 2010 Dec; 85(12):947-50. PMID: 21108326.
    Citations: 9     Fields:    Translation:Humans
  62. Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol. 2010 Jun; 85(6):440-2. PMID: 20309856.
    Citations: 4     Fields:    Translation:Humans
  63. Van Cott EM. All that glitters is gold? Am J Hematol. 2010 Apr; 85(4):223-4. PMID: 20162542.
    Citations:    Fields:    Translation:Humans
  64. Takahashi K, Chang WC, Takahashi M, Pavlov V, Ishida Y, La Bonte L, Shi L, Fujita T, Stahl GL, Van Cott EM. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology. 2011 Jan-Feb; 216(1-2):96-102. PMID: 20399528.
    Citations: 30     Fields:    Translation:AnimalsCells
  65. Castellone DD, Van Cott EM. Laboratory monitoring of new anticoagulants. Am J Hematol. 2010 Mar; 85(3):185-7. PMID: 20131309.
    Citations: 10     Fields:    Translation:Humans
  66. Lane AA, Van Cott EM, Dey BR. von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathy. Am J Hematol. 2010 Feb; 85(2):134-5. PMID: 20095032.
    Citations:    Fields:    Translation:Humans
  67. Lee-Lewandrowski E, Nichols J, Van Cott E, Grisson R, Louissaint A, Benzer T, Lewandrowski K. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol. 2009 Sep; 132(3):326-31. PMID: 19687307.
    Citations: 11     Fields:    Translation:Humans
  68. Van Cott EM. Point-of-care testing in coagulation. Clin Lab Med. 2009 Sep; 29(3):543-53. PMID: 19840686.
    Citations:    Fields:    Translation:Humans
  69. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009 Aug; 61(2):325-32. PMID: 19615543.
    Citations: 21     Fields:    Translation:Humans
  70. Shaikh S, Van Cott EM. The effect of argatroban on activated protein C resistance. Am J Clin Pathol. 2009 Jun; 131(6):828-33. PMID: 19461089.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  71. Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clin Lab Med. 2009 Jun; 29(2):339-66. PMID: 19665682.
    Citations: 4     Fields:    Translation:Humans
  72. Peerschke EI, Castellone DD, Ledford-Kraemer M, Van Cott EM, Meijer P. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience. Am J Clin Pathol. 2009 Apr; 131(4):552-8. PMID: 19289591.
    Citations: 11     Fields:    Translation:Humans
  73. Foerch C, Arai K, Van Cott EM, van Leyen K, Lo EH. Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab. 2009 May; 29(5):1015-21. PMID: 19319147.
    Citations: 13     Fields:    Translation:HumansAnimals
  74. Chia S, Van Cott EM, Raffel OC, Jang IK. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation. Thromb Haemost. 2009 Mar; 101(3):535-40. PMID: 19277416.
    Citations: 1     Fields:    Translation:Humans
  75. Staropoli JF, Van Cott EM, Makar RS. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance. Transfusion. 2008 Nov; 48(11):2435-41. PMID: 18673345.
    Citations:    Fields:    Translation:Humans
  76. Harris K, Nguyen P, Van Cott EM. Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopenia. Am J Clin Pathol. 2008 Feb; 129(2):282-6. PMID: 18208809.
    Citations: 4     Fields:    Translation:HumansCells
  77. Olson JD, Brandt JT, Chandler WL, Van Cott EM, Cunningham MT, Hayes TE, Kottke-Marchant KK, Makar RS, Uy AB, Wang EC. Laboratory reporting of the international normalized ratio: progress and problems. Arch Pathol Lab Med. 2007 Nov; 131(11):1641-7. PMID: 17979481.
    Citations: 3     Fields:    Translation:Humans
  78. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007 Jun; 131(6):890-901. PMID: 17550316.
    Citations: 5     Fields:    Translation:Humans
  79. Salem RO, Van Cott EM. A new automated screening assay for the diagnosis of von Willebrand disease. Am J Clin Pathol. 2007 May; 127(5):730-5. PMID: 17439831.
    Citations: 3     Fields:    Translation:Humans
  80. Cunningham MT, Brandt JT, Chandler WL, Eby CS, Hayes TE, Krishnan J, Lefkowitz JB, Olson JD, Stasik CJ, Teruya J, Van Cott EM. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2007 Apr; 33(3):250-8. PMID: 17427059.
    Citations: 1     Fields:    Translation:HumansCells
  81. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7. PMID: 17257993.
    Citations: 9     Fields:    Translation:Humans
  82. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med. 2007 Feb; 131(2):293-6. PMID: 17284116.
    Citations: 8     Fields:    Translation:Humans
  83. Laposata M, Van Cott EM, Lev MH. Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status. N Engl J Med. 2007 Jan 11; 356(2):174-82. PMID: 17215536.
    Citations: 4     Fields:    Translation:Humans
  84. Smogorzewska A, Brandt JT, Chandler WL, Cunningham MT, Hayes TE, Olson JD, Kottke-Marchant K, Van Cott EM. Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing. Arch Pathol Lab Med. 2006 Nov; 130(11):1605-11. PMID: 17076521.
    Citations: 6     Fields:    Translation:Humans
  85. Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7. PMID: 16875910.
    Citations: 2     Fields:    Translation:Humans
  86. Hayes TE, Brandt JT, Chandler WL, Eby CS, Kottke-Marchant K, Krishnan J, Lefkowitz JB, Olson JD, Rund CR, Van Cott EM, Cunningham MT. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2006 Jul; 32(5):499-504. PMID: 16862523.
    Citations: 3     Fields:    Translation:Humans
  87. Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21. PMID: 16860036.
    Citations:    Fields:    Translation:Humans
  88. Kratz A, Wood MJ, Siegel AJ, Hiers JR, Van Cott EM. Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activation. Am J Clin Pathol. 2006 Feb; 125(2):296-300. PMID: 16393676.
    Citations: 7     Fields:    Translation:HumansCells
  89. Kratz A, Stanganelli N, Van Cott EM. A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Arch Pathol Lab Med. 2006 Jan; 130(1):39-44. PMID: 16390236.
    Citations: 3     Fields:    Translation:Humans
  90. Gettings EM, Brush KA, Van Cott EM, Hurford WE. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Crit Care. 2006; 10(6):R161. PMID: 17109753.
    Citations: 5     Fields:    Translation:Humans
  91. Refaai MA, Lukoszyk M, Hughes J, Eby CS, Van Cott EM. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming. Am J Clin Pathol. 2005 Dec; 124(6):972; author reply 973. PMID: 16416745.
    Citations:    Fields:    Translation:Humans
  92. Kratz A, Bengtsson HI, Casey JE, Keefe JM, Beatrice GH, Grzybek DY, Lewandrowski KB, Van Cott EM. Performance evaluation of the CellaVision DM96 system: WBC differentials by automated digital image analysis supported by an artificial neural network. Am J Clin Pathol. 2005 Nov; 124(5):770-81. PMID: 16203273.
    Citations: 13     Fields:    Translation:Humans
  93. Van Cott EM, Ledford-Kraemer M, Meijer P, Nichols WL, Johnson SM, Peerschke EI. Protein S assays: an analysis of North American Specialized Coagulation Laboratory Association proficiency testing. Am J Clin Pathol. 2005 May; 123(5):778-85. PMID: 15981819.
    Citations: 1     Fields:    Translation:Humans
  94. Arpino PA, Demirjian Z, Van Cott EM. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Pharmacotherapy. 2005 Feb; 25(2):157-64. PMID: 15767231.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  95. Van Cott EM, Fletcher SR, Kratz A. Effects of the blood-collection tube material and long-term storage on platelet activation parameters on the ADVIA 120/2120 hematology system. Lab Hematol. 2005; 11(1):71-5. PMID: 15790555.
    Citations: 3     Fields:    Translation:Humans
  96. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med. 2004 Dec; 128(12):1424-7. PMID: 15578888.
    Citations: 12     Fields:    Translation:Humans
  97. Van Cott EM, Laposata M, Hartnett ME. Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis. 2004 Jul; 15(5):393-7. PMID: 15205587.
    Citations: 3     Fields:    Translation:Humans
  98. Comunale ME, Van Cott EM. Heparin-induced thrombocytopenia. Int Anesthesiol Clin. 2004; 42(3):27-43. PMID: 15205638.
    Citations: 3     Fields:    Translation:HumansCells
  99. Smith EY, Charles LA, Van Cott EM. Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol. 2004 Jan; 121(1):138-41. PMID: 14750251.
    Citations: 5     Fields:    Translation:Humans
  100. Florez JC, Ay H, Van Cott EM, Buonanno FS. Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis. 2003 May-Jun; 12(3):114-8. PMID: 17903914.
    Citations: 6     Fields:    
  101. Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol. 2003 Apr; 119(4):497-504. PMID: 12710122.
    Citations: 1     Fields:    Translation:HumansCells
  102. Hartnett ME, Laposata M, Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol. 2003 Apr; 135(4):542-4. PMID: 12654376.
    Citations: 2     Fields:    Translation:Humans
  103. Refaai MA, Laposata M, Van Cott EM. Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Am J Clin Pathol. 2003 Jan; 119(1):61-5. PMID: 12520698.
    Citations: 2     Fields:    Translation:Humans
  104. Van Cott EM, Lewandrowski KB, Patel S, Grzybek DY, Patel HS, Fletcher SR, Kratz A. Comparison of glass K3EDTA versus plastic K2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials. Lab Hematol. 2003; 9(1):10-4. PMID: 12661823.
    Citations:    Fields:    Translation:Humans
  105. Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol. 2002 Dec; 118(6):856-63. PMID: 12472278.
    Citations: 42     Fields:    Translation:Humans
  106. Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med. 2002 Nov; 126(11):1281-95. PMID: 12421136.
    Citations: 5     Fields:    Translation:Humans
  107. Van Cott EM, Smith EY, Galanakis DK. Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin time. Am J Clin Pathol. 2002 Aug; 118(2):263-8. PMID: 12162688.
    Citations: 1     Fields:    Translation:Humans
  108. Van Cott EM, Soderberg BL, Laposata M. Hypercoagulability test strategies in the protein C and protein S pathway. Clin Lab Med. 2002 Jun; 22(2):391-403. PMID: 12134467.
    Citations:    Fields:    Translation:Humans
  109. Van Cott EM, Soderberg BL, Laposata M. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. Arch Pathol Lab Med. 2002 May; 126(5):577-82. PMID: 11958664.
    Citations: 3     Fields:    Translation:Humans
  110. Nestoridi E, Buonanno FS, Jones RM, Krishnamoorthy K, Grant PE, Van Cott EM, Grabowski EF. Arterial ischemic stroke in childhood: the role of plasma-phase risk factors. Curr Opin Neurol. 2002 Apr; 15(2):139-44. PMID: 11923626.
    Citations: 8     Fields:    Translation:Humans
  111. Van Cott E, Laposata M. Cysteine and venous thrombosis: a case report. Am J Clin Pathol. 2002 Jan; 117(1):168. PMID: 11789724.
    Citations:    Fields:    Translation:Humans
  112. Siegel AJ, Stec JJ, Lipinska I, Van Cott EM, Lewandrowski KB, Ridker PM, Tofler GH. Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 2001 Oct 15; 88(8):918-20, A9. PMID: 11676965.
    Citations: 15     Fields:    Translation:Humans
  113. Palmer-Toy DE, Szczepiorkowski ZM, Shih V, Van Cott EM. Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood. Clin Chem. 2001 Sep; 47(9):1704-7. PMID: 11514408.
    Citations: 3     Fields:    Translation:Humans
  114. Van Cott EM. Coagulation point-of-care testing. Clin Lab Med. 2001 Jun; 21(2):337-50. PMID: 11396087.
    Citations: 1     Fields:    Translation:Humans
  115. Laposata M, Van Cott EM. How to work up hypercoagulability. CAP Today. 2000 Jan; 14(1):24-6. PMID: 10788290.
    Citations:    Fields:    Translation:Humans
  116. Muszbek L, Haramura G, Cluette-Brown JE, Van Cott EM, Laposata M. The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids. Lipids. 1999; 34 Suppl:S331-7. PMID: 10419194.
    Citations: 8     Fields:    Translation:HumansCells
  117. Van Cott EM, Laposata M. Laboratory evaluation of hypercoagulable states. Hematol Oncol Clin North Am. 1998 Dec; 12(6):1141-66, v. PMID: 9922930.
    Citations: 5     Fields:    Translation:Humans
  118. Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998 Sep; 122(9):799-807. PMID: 9740137.
    Citations: 25     Fields:    Translation:Humans
  119. Van Cott EM, Grabowski EF. Vascular hemostasis in flowing blood in children. Semin Thromb Hemost. 1998; 24(6):583-90. PMID: 10066154.
    Citations: 1     Fields:    Translation:HumansAnimals
  120. Van Cott EM, Muszbek L, Laposata M. Fatty acid acylation of platelet proteins. Prostaglandins Leukot Essent Fatty Acids. 1997 Jul; 57(1):33-7. PMID: 9250606.
    Citations:    Fields:    Translation:HumansCells
  121. Van Cott EM. How to diagnose and manage heparin-induced thrombocytopenia. CAP Today. 1997 Mar; 11(3):50-4. PMID: 10166432.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Van Cott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (393)
Explore
_
Co-Authors (71)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.